As coronavirus poses a serious threat to many countries around the world, many countries around the world are experimenting with vaccines to control this deadly virus.
Bharat Biotech has announced the commencement of Phase III trials of Covaxin. The Phase III trials will involve 26,000 volunteers across India, conducted in partnership with ICMR. It is the largest clinical trial conducted for a Covid-19 vaccine in India.
“This is India’s first phase three efficacy study for a Covid-19 vaccine, and the largest phase III efficacy trial ever conducted in India. The trial has been registered at www.ctri.nic.in and approved by the Drugs Controller General of India.”
Trial volunteers will receive two intramuscular injections approximately 28 days apart. Participants will be randomly assigned to receive Covaxin or placebo. The trial is double-blinded, such that the investigators, the participants, and the company will not be aware of who is assigned to which group.
On proceeding further Bharat Biotech has stated that “Covaxin has been evaluated in 1000 subjects in Phase I and Phase II clinical trials, with promising safety and immunogenicity data. Volunteers who wish to participate in this trial should be adults over 18 years of age”.
Russia’s Information on COVID-19 Vaccine:
Also, In this case, the 12th BRICS conference was held via video. It was attended by Indian Prime Minister Narendra Modi, Russian President Putin, Chinese President Xi Jinping, Brazilian President Jar Bolzano, and South African President Cyril Ramaphosa.
Speaking at the time, Russian President Vladimir Putin said: The Sputnik V vaccine was first registered in August.
The vaccine can also be manufactured in India and China. Russia’s direct investment body has signed an agreement with Brazil and India to test the Sputnik V vaccine. It has also entered into agreements with Indian and Chinese companies to produce the vaccine.
Agreements have been reached to distribute the vaccine to other countries in the world besides the countries concerned, Putin said. The Russian Ministry of Health reports that the Sputnik V vaccine is 92 percent effective in preventing corona.
A year from now, India is likely to be in the midst of a massive vaccination initiative. There are long days ahead. But there’s reason to remain positive about prospects of getting vaccinated in India. In the meantime, continue to socially distance, wear masks, and so on.